Close
Digital Health & Ai Innovation summit 2026
APE 2026

McKesson Awards $1.3 Million to Researchers Studying on Mobile Technology

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Supplier Quality Management in Complex Pharma...

Overseeing the intricate web of global providers for raw materials and contract services is essential for ensuring product safety and maintaining a resilient pharmaceutical supply chain in a volatile market.

GMP Audits Driving Continuous Quality Excellence

Far from being mere regulatory hurdles, internal and external Good Manufacturing Practice assessments serve as vital catalysts for institutional growth and the pursuit of operational perfection in pharmaceutical production.

Digital Quality Systems Transforming Compliance Models

The transition from manual quality assurance to integrated digital platforms is redefining how pharmaceutical and medical device companies maintain regulatory readiness and operational agility.

Feb 22nd 2011 :- The McKesson Foundation announced the six recipients of $1.3 million in research grants as part of its Mobilizing for Healthsm initiative to improve the health of underserved populations with chronic diseases through the use of mobile-phone technology. The Mobilizing for Healthsm grants, of up to $250,000 each, will support studies on diabetes care and management at six esteemed U.S. institutions. The Mobilizing for Health grant program dedicates $1.5 million annually to research grants and field-building activities, such as mobile health conference support and other mHealth field building activities.

Mobile health, or “mHealth,” is a term used for the practice of medicine that relies on wireless devices, such as mobile phones, PDAs and remote monitoring devices, to improve patient care.

The studies will examine a range of mobile-health technology options from sending simple SMS text messages to patients to remind them to take their medications to a comprehensive mobile phone-based software program that is integrated with patients’ electronic medical records. Each study will be completed within one year, several will test bilingual (Spanish and English) messaging strategies, and all are designed around patient populations served by community health clinics.

Carrie Varoquiers, president of the McKesson Foundation said, These studies are part of an ongoing Foundation effort to tie innovative technologies to low-cost, scalable health solutions in order to better help patients manage their chronic conditions. Through initiatives like Mobilizing for Healthsm, the McKesson Foundation is committed to increasing access to affordable, high-quality healthcare for all.

 

Latest stories

Related stories

Supplier Quality Management in Complex Pharma Networks

Overseeing the intricate web of global providers for raw materials and contract services is essential for ensuring product safety and maintaining a resilient pharmaceutical supply chain in a volatile market.

GMP Audits Driving Continuous Quality Excellence

Far from being mere regulatory hurdles, internal and external Good Manufacturing Practice assessments serve as vital catalysts for institutional growth and the pursuit of operational perfection in pharmaceutical production.

Digital Quality Systems Transforming Compliance Models

The transition from manual quality assurance to integrated digital platforms is redefining how pharmaceutical and medical device companies maintain regulatory readiness and operational agility.

Advancing Data Integrity Across Biotech Manufacturing

Ensuring the accuracy and reliability of information is the lifeblood of biotechnology production, where even minor discrepancies in digital or physical records can compromise product safety and regulatory standing.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »